LOXO-RET-18037

Status: Active Trial | Marker: RET Title A Multi-Center Expanded Access Program (EAP) for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors with Rearranged During Transfection (RET) Activation (LIBRETTO-201) Study Number NCT03906331 Indication...